HD
25
-10
CHK
41
2
ROK
42
3
GWW
58
-2
IFF
44
-3
AIV
61
10
EW
40
-2
PSX
42
-12
VNO
61
-2
AES
49
-5
PNW
48
-11
WHR
35
-11
BIIB
38
2
CFG
40
-6
KMI
46
-2
K
41
-3
SBUX
50
-2
DO
49
-5
DOW
47
-5
UAL
58
2
HD
25
-10
CHK
41
2
ROK
42
3
GWW
58
-2
IFF
44
-3
AIV
61
10
EW
40
-2
PSX
42
-12
VNO
61
-2
AES
49
-5
PNW
48
-11
WHR
35
-11
BIIB
38
2
CFG
40
-6
KMI
46
-2
K
41
-3
SBUX
50
-2
DO
49
-5
DOW
47
-5
UAL
58
2
Financhill
Back

Puma Biotechnology 10K Form

Sell
41

PBYI
Puma Biotechnology

Last Price:
5.03
Seasonality Move:
6.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PBYI News And Ratings

See the #1 stock for the next 7 days that we like better than PBYI

PBYI Financial Statistics

Sales & Book Value

Annual Sales: $235.64M
Cash Flow: $10.41M
Price / Cash Flow: 16.61
Annual Sales: $1.12
Price / Book: 4.53

Profitability

EPS (TTM): 0.45000
Net Income (TTM): $21.59M
Gross Margin: $172.96M
Return on Equity: 63.49%
Return on Assets: 10.25%

Puma Biotechnology Earnings Forecast

Key Puma Biotechnology Financial Ratios

  • The Gross Profit Margin over the past 16 years for PBYI is 73.40%.
  • The Selling, General & Administrative Expenses for PBYI have been equal to 37.53% of Gross Profit Margin.
  • The Research & Development expenses have been 21.38% of Revenue.
  • The Interest Expense is 61.74% of Operating Income.
  • The Net Earning history of PBYI is 9.16% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

Puma Biotechnology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PBYI
CUSIP: 74587V
Website: pumabiotechnology.com

Debt

Debt-to-Equity Ratio: 1.86
Current Ratio: 1.57
Quick Ratio: 1.45

Price-to-Earnings

Trailing P/E Ratio: 11.16
Forward P/E Ratio: 9.56

PBYI Technical Analysis vs Fundamental Analysis

Sell
41
Puma Biotechnology (PBYI) is a Sell

Is Puma Biotechnology a Buy or a Sell?